当前位置:首页 - 行情中心 - 梅花生物(600873) - 财务分析

梅花生物

(600873)

  

流通市值:319.80亿  总市值:319.80亿
流通股本:28.53亿   总股本:28.53亿

梅花生物(600873)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润7.52亿元,每股收益0.26元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益1486533.33万元,未分配利润1017942.67万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产2343394.73万元,负债856861.40万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入6,486,560,309.2427,760,612,259.0720,526,171,453.7513,588,270,517.23
营业总成本5,754,966,816.9124,158,622,97218,070,945,779.4911,941,801,915.19
营业利润885,853,023.133,813,393,394.362,585,110,468.681,657,065,875
利润总额875,531,219.873,723,135,620.152,534,617,204.041,613,487,780.68
净利润751,704,565.793,180,949,695.482,160,513,951.071,370,843,964.88
其他综合收益10,898,041.98-535,384,994.54287,459,668.83919,739,712.58
综合收益总额762,602,607.772,645,564,700.942,447,973,619.92,290,583,677.46
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计9,608,806,563.49,507,311,168.59,434,691,396.998,840,203,051.13
非流动资产合计13,825,140,752.9113,649,868,686.7514,798,946,512.6115,553,053,774.35
资产总计23,433,947,316.3123,157,179,855.2524,233,637,909.624,393,256,825.48
流动负债合计6,442,166,396.966,528,739,033.976,754,970,538.846,285,412,723.75
非流动负债合计2,126,447,645.282,465,426,007.613,298,181,152.553,853,588,349.57
负债合计8,568,614,042.248,994,165,041.5810,053,151,691.3910,139,001,073.32
归属于母公司股东权益合计14,865,333,274.0714,163,014,813.6714,180,486,218.2114,254,255,752.16
股东权益合计14,865,333,274.0714,163,014,813.6714,180,486,218.2114,254,255,752.16
负债和股东权益合计23,433,947,316.3123,157,179,855.2524,233,637,909.624,393,256,825.48
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计6,789,691,782.8730,033,311,519.622,505,535,051.4614,518,821,716.54
经营活动现金流出小计6,820,094,144.8124,804,374,434.7217,621,248,868.9212,248,329,423.22
经营活动产生的现金流量净额-30,402,361.945,228,937,084.884,884,286,182.542,270,492,293.32
投资活动现金流入小计67,834,032.41124,444,307.3929,103,914.526,770,175.22
投资活动现金流出小计559,646,744.881,633,590,541.621,482,987,072.711,466,219,738.11
投资活动产生的现金流量净额-491,812,712.47-1,509,146,234.23-1,453,883,158.21-1,439,449,562.89
筹资活动现金流入小计1,950,928,102.764,506,797,386.823,597,740,538.771,655,800,299.47
筹资活动现金流出小计1,790,496,521.597,614,894,578.995,983,767,925.43,530,615,737.25
筹资活动产生的现金流量净额160,431,581.17-3,108,097,192.17-2,386,027,386.63-1,874,815,437.78
汇率变动对现金及现金等价物的影响27,345,563.8540,121,088.5330,638,811.2414,617,987.23
现金及现金等价物净增加额-334,437,929.39651,814,747.011,075,014,448.94-1,029,154,720.12
期末现金及现金等价物余额4,446,176,513.344,780,614,442.735,203,814,144.663,099,644,975.6
最新报告期:2024-04-15
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
中信建投邓天泽1.101.331.442024-04-15
国联证券柴沁虎1.101.201.302024-04-09
民生证券刘海荣1.031.071.142024-04-09
中邮证券张泽亮1.101.301.442024-04-09
华泰证券张雄,庄汀洲1.121.281.382024-04-08
TOP↑